Top Portland, OR Biotech Companies (26)
Don't see your company?
Create a company profile
Schrödinger is a leading provider of advanced molecular simulations and enterprise software solutions and services for pharmaceutical, biotechnology, and materials science research. The predictive power of Schrödinger's software allows scientists to accelerate their research and development, reduce research costs, and make novel discoveries.
Dexcom develops, manufactures and distributes continuous glucose monitoring systems for diabetes management.
Trusted by the world's leading organizations, Point B is a consulting firm that works at the intersection of expertise, industry insight, and transformative technology. This collaborative approach enables you to solve your most important challenges, by bringing together the right mix of talent and technology to deliver greater value and impact. With over 850 associates in the US and 3000+ consultants around the world through our Nextcontinent partnership, we work where you do to deliver the change you seek.
AbSci is a leading synthetic biology company that translates ideas into drugs with a platform technology that reinvents the biopharmaceutical drug discovery process.
Considered the founder of the industry, Genentech, now a member of the Roche Group, has been delivering on the promise of biotechnology for more than 40 years. Genentech is a biotechnology company dedicated to pursuing groundbreaking science to discover and develop medicines for people with serious and life-threatening diseases. Our transformational discoveries include the first targeted antibody for cancer and the first medicine for primary progressive multiple sclerosis. We're passionate about finding solutions for people facing the world's most difficult-to-treat conditions. That is why we use cutting-edge science to create and deliver innovative medicines around the globe. To us, science is personal. Making a difference in the lives of millions starts when you make a change in yours.
Circumvent Pharmaceuticals is a Pharmaceuticals company.
Pdx Pharmaceuticals is a Pharmaceutical company located in Portland.
Veana Therapeutics is dedicated to developing innovative, safe, cancer fighting medicines Veana’s VIMO technology is based on orally bioavailable anti-cancer agents that selectively attack and destroy the energy powerhouses (mitochondria) of cancer cells in a fashion that subsequently stimulates the immune system. Veana’s VIMO platform of α-TEA salt form-based products can be combined with other forms of immunotherapy to further improve anti-tumor activity.
UbiVac is a clinical stage biotech engaged in research and development, and manufacture, of therapeutic immune activators, vaccines and cellular immunotherapies to combat cancer. Used in combination with other immunotherapies, UbiVac’s patented technologies have proven highly effective at improving survival and apparent cure in difficult to treat animal cancers (PMID: 27874054; PMID: 31747946; PMID: 22068657). UbiVac believes that the explanation for this effectiveness lies in several high impact publications from 2021 identifying a previously unknown class of shared non-mutated cancer neoantigens that make up as much as 25% of the antigens on cancer cells (PMID: 33740418; PMID: 33691108; PMID: 34663921). As the non-mutated shared cancer neoantigens are short-lived proteins, the majority are expected to be contained in UbiVac’s DPV-001. Importantly, these findings help explain why UbiVac’s immunotherapy provided cross-protective cancer immunity in preclinical models, something that had not been observed in 50 years of study (PMID: 21810919). These remarkable studies raised the possibility of off-the-shelf Universal Cancer Vaccines (PMID: 33852826). UbiVac has completed an NCI-funded phase I/II adjuvant trial of its lead agent, DPV-001. This trial met its endpoints, determined safety, identified drug formulation, and demonstrated proof-of-concept. Based on these data UbiVac partnered with the Providence Cancer Institute and Incyte on a first-in-human immunotherapy trial of UbiVac’s DPV-001, anti-GITR and anti-PD-1 for advanced HNSCC. The first patients were treated in Q4 2021, and preliminary immunological monitoring data will be presented at AACR in April 2022. UbiVac also has a pipeline of cellular therapies under development. Given that UbiVac’s CEO and CSO, together, have 55+ years of experience with preclinical and clinical studies of adoptive immunotherapy, UbiVac is well positioned to bring their innovative cellular therapy platforms to the clinic.
FloraWorks is a specialized biotech enterprise discovering rare and novel cannabinoids for commercial and therapeutic applications. We develop and patent scaled manufacturing pathways for cannabinoids with a high potential for therapeutic use while also completing the required toxicology and efficacy research to bring them to market.
Aronora A biotech company focusing on the development of safer biologic drugs.
DesignMedix develops pharmaceutical drugs designed to address the rapid rise in drug resistance in multiple diseases.
A Delaware C-corporation that is focused on therapeutic uses of inert gas mixtures.
Elex Biotech Inc is a drug discovery and development company focused on first-in-class new chemical entities (NCEs) for the treatment of arrhythmia and heart failure. Using rational drug design and an internally generated SAR database, the Company has generated ~200 NCEs that stabilize mutant or dysfunctional Ryanodine receptor type 2 (RyR2), the Ca release channel that regulates the strength and frequency of heart muscle contractions. Certain arrhythmias and heart failure share a common defect in Ca handling resulting from RyR2 dysfunction that is addressed by Elex Biotech’s compounds. Elex Biotech has demonstrated in vivo proof of concept in animal models of catecholaminergic polymorphic ventricular tachycardia (CPVT), an orphan disease estimated to cause 15% of unexplained sudden cardiac death in apparently healthy young people.
CiiTA is provides expertise and actionable intelligence to pharmaceutical and biotechnology manufacturers.
Personalized health and wellness programs based on human behavior research.
MolecularMD provides molecular diagnostics products and services to support clinical development and commercialization of cancer therapies.
Galena Biopharma, Inc. is focused on discovering, developing and commercializing innovative therapies.
AgonOx is a cure for many types of cancer will be found through harnessing the power of the immune system
Capsa Solutions, Rubbermaid Healthcare, Kirby Lester, and RoboPharma have been fully integrated to form Capsa Healthcare. Collectively, our passion as a single organization is born out of the same commitment and purpose that our customers have to providing superior patient care. We understand the delivery of healthcare cannot wait; our customers rely on our products and support to deliver superior clinical efficiency and medication management accuracy. For acute care facilities, extended care facilities, pharmacies, and central filling operations, we continually invest in product development, technology innovation, service, and support to make sure we are the logical choice for products that elevate the performance of healthcare delivery at every point-of-care. For more than 50 years, Capsa has been a leading developer of mobile storage and technology products that improve user workflow, process efficiency, and healthcare outcomes. Headquartered in Columbus, OH, we operate facilities in Portland, OR, Lake Forest, IL, Huntersville, NC, Waalwijk, The Netherlands, and Agua Prieta, Mexico, and have distribution partners in more than 70 countries.
Work Your Passion. Live Your Purpose.
